IOVA
Iovance Biotherapeutics Inc
12.90$
-0.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.05 | -0.02 | -0.95 | -8.15 | -2.81 | -0.38 | -0.35 | -0.41 | -0.59 | -1.21 | -1.04 | -1.28 | -1.48 | -1.49 | -1.84 | -1.54 | -1.22 | -0.85 | |
| 0.00 | 0.00 | 0.09 | 0.00 | 0.01 | 0.00 | 0.00 | 0.02 | 0.02 | 0.01 | 0.01 | 0.07 | 0.01 | 0.09 | 0.13 | 0.14 | 0.15 | 0.10 | |
| – | – | – | – | – | 2.02 | 0.15 | 0.19 | 0.34 | 0.18 | 0.21 | 0.20 | 0.30 | 0.45 | 0.53 | 0.27 | 0.38 | 0.17 | |
| – | – | – | 3.23 | -6.65 | 0.10 | 0.15 | 0.19 | 0.34 | 0.18 | 0.21 | 0.19 | 0.30 | 0.45 | 0.53 | – | – | – | |
| 0.00 | 0.00 | 0.03 | 0.47 | 1.86 | -0.03 | -0.02 | -0.01 | 0.01 | 0.01 | 0.03 | -0.02 | 0.02 | 0.16 | -0.02 | -0.03 | -0.42 | -0.07 | |
| 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.06 | 0.03 | 0.03 | 0.02 | 0.01 | 0.06 | 0.34 | 0.24 | 0.13 | 0.09 | 0.04 | 0.09 | |
| – | – | – | -0.11 | 0.00 | 0.00 | -0.06 | -2.05 | 0.16 | 0.90 | -3.97 | 0.72 | -2.30 | 0.00 | 1.61 | -0.66 | -0.33 | 0.13 | |
| – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.89 | 0.00 | – | – | – | 0.01 | – | – | – | – | |
| – | – | – | 1.15 | 0.31 | 2.36 | 1.42 | 1.76 | -0.01 | -0.02 | 0.00 | 0.00 | 0.00 | 0.01 | -0.02 | 0.01 | – | 0.00 | |
| – | – | – | 6.08 | – | 0.03 | – | – | – | – | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | – | – | |
| – | 0.02 | 2.92 | 7.23 | 2.17 | 2.39 | 1.42 | 1.76 | 1.75 | 0.90 | 4.36 | 0.05 | 4.17 | 1.56 | 1.19 | 1.97 | 1.35 | 0.84 | |
| -0.05 | 0.01 | 1.97 | -1.03 | -0.64 | 2.01 | 1.01 | -0.70 | 1.32 | 0.59 | -0.65 | -0.50 | 0.39 | 0.07 | 0.97 | -0.24 | -0.20 | 0.13 | |
| -0.05 | -0.02 | -0.95 | -8.19 | -2.81 | -0.38 | -0.41 | -0.44 | -0.62 | -1.22 | -1.05 | -1.33 | -1.82 | -1.73 | -1.97 | -1.63 | -1.26 | -0.94 |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.